title: Fusobacterium is associated with colorectal adenomas.
abstract: The human gut microbiota is increasingly recognized as a player in colorectal cancer (CRC). While particular imbalances in the gut microbiota have been linked to colorectal adenomas and cancer, no specific bacterium has been identified as a risk factor. Recent studies have reported a high abundance of Fusobacterium in CRC subjects compared to normal subjects, but this observation has not been reported for adenomas, CRC precursors. We assessed the abundance of Fusobacterium species in the normal rectal mucosa of subjects with (n = 48) and without adenomas (n = 67). We also confirmed previous reports on Fusobacterium and CRC in 10 CRC tumor tissues and 9 matching normal tissues by pyrosequencing. We extracted DNA from rectal mucosal biopsies and measured bacterial levels by quantitative PCR of the 16S ribosomal RNA gene. Local cytokine gene expression was also determined in mucosal biopsies from adenoma cases and controls by quantitative PCR. The mean log abundance of Fusobacterium or cytokine gene expression between cases and controls was compared by t-test. Logistic regression was used to compare tertiles of Fusobacterium abundance. Adenoma subjects had a significantly higher abundance of Fusobacterium species compared to controls (p = 0.01). Compared to the lowest tertile, subjects with high abundance of Fusobacterium were significantly more likely to have adenomas (OR 3.66, 95% CI 1.37-9.74, p-trend 0.005). Cases but not controls had a significant positive correlation between local cytokine gene expression and Fusobacterium abundance. Among cases, the correlation for local TNF-α and Fusobacterium was r = 0.33, p = 0.06 while it was 0.44, p = 0.01 for Fusobacterium and IL-10. These results support a link between the abundance of Fusobacterium in colonic mucosa and adenomas and suggest a possible role for mucosal inflammation in this process.
authors: Center for Gastrointestinal Biology and Disease, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
authors: Amber N
authors: AN
authors: McCoy
authors: Félix
authors: F
authors: Araújo-Pérez
authors: Andrea
authors: A
authors: Azcárate-Peril
authors: Jen Jen
authors: JJ
authors: Yeh
authors: Robert S
authors: RS
authors: Sandler
authors: Temitope O
authors: TO
authors: Keku
mesh_terms: D000236:Adenoma / Q000235:genetics / Q000382:microbiology* / Q000473:pathology; D000328:Adult; D000368:Aged; D001706:Biopsy; D016022:Case-Control Studies; D003106:Colon / Q000378:metabolism / Q000382:microbiology; D015179:Colorectal Neoplasms / Q000235:genetics / Q000382:microbiology* / Q000473:pathology; D016207:Cytokines / Q000235:genetics; D005260:Female; D005673:Fusobacterium / Q000235:genetics* / Q000378:metabolism*; D015870:Gene Expression; D006801:Humans; D007249:Inflammation / Q000378:metabolism / Q000382:microbiology / Q000473:pathology; D007413:Intestinal Mucosa / Q000382:microbiology / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D012329:RNA, Bacterial; D012336:RNA, Ribosomal, 16S; D015203:Reproducibility of Results; D012307:Risk Factors
chemical_list: D016207:Cytokines; D012329:RNA, Bacterial; D012336:RNA, Ribosomal, 16S